ecancer

NCI CARs for childhood ALL and neuroblastoma: the promise and potential pitfalls

Dr Daniel Lee - University of Virginia, Charlottesville, USA

23 Sep 2016

Immune strategies for treating neuroblastoma

Dr Karin Straathof - UCL Institute of Child Health, London, UK

23 Sep 2016

Targetted medicine to reduce melanoma mutational burden

Prof Grant McArthur - The Royal Melbourne Hospital, Melbourne, Australia

22 Sep 2016

Future smart surgical approaches for brain metastases

Dr Francesco Di Meco - Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

14 Sep 2016

The changing process of drug discovery and design

Dr Ian Waddell - Cancer Research UK Manchester Institute, Manchester, UK

14 Jul 2016

Glioblastoma heterogeneity in circulating tumour DNA

Dr Joan Seoane - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain

14 Jul 2016

Editor's ASCO 2016 Roundup

Prof Gordon McVie - ecancer Editor in Chief

16 Jun 2016

Subset of anaplastic glioma patients benefit from adjuvant chemo

Dr Martin van den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands

6 Jun 2016

ASCO 2016: Plenary Session Review

Dr Julie Vose - President of ASCO

5 Jun 2016

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Prof James Perry - University of Toronto, Toronto, Canada

5 Jun 2016

Elderly patients with glioblastoma live longer with chemoradiation using temozolomide

Prof James Perry - University of Toronto, Toronto, Canada

5 Jun 2016

Temozolomide after radiotherapy improves glioma survival

Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands

3 Jun 2016

More from ecancer